FDA Approved: NINLARO — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

FDA approved a supplemental application for NINLARO (ixazomib) submitted by Takeda Pharmaceuticals America, resulting in an updated approval for the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• NINLARO (ixazomib)

Snippet

SUPPL AP for NINLARO (IXAZOMIB)